An Associated Press investigation alleges the Drug Enforcement Administration (DEA) deliberately allowed a surge of fentanyl pills into New Mexico to pursue investigations targeting larger drug trafficking organizations. The report claims the DEA intentionally did not intervene to stop the flow of the deadly opioid at the street level, prioritizing the development of cases against higher-level suppliers. Critics argue this strategy resulted in increased overdose deaths and community harm within the state. The DEA has not yet publicly responded to the specific allegations detailed in the AP report. The investigation raises questions about the agency’s tactics and resource allocation in combating the fentanyl crisis. The AP based its findings on interviews and internal DEA documents, suggesting a calculated decision to tolerate increased fentanyl availability for investigative purposes. This approach is now facing scrutiny regarding its ethical and public safety implications.